The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets

Bertrand Allard(Groupe d'Oncologie Radiothérapie Tête et Cou), John Stagg(Institute for Research in Immunology and Cancer), Simon C. Robson(Beth Israel Deaconess Medical Center), Maria Serena Longhi(Beth Israel Deaconess Medical Center)
Immunological Reviews
March 1, 2017
Cited by 901


Related Papers